Kyle Clifford Cuneo, MD - Medicare Radiation Oncology in Alpena, MI

Kyle Clifford Cuneo, MD is a medicare enrolled "Radiology - Radiation Oncology" physician in Alpena, Michigan. He went to Vanderbilt University School Of Medicine and graduated in 2007 and has 17 years of diverse experience with area of expertise as Radiation Oncology. He is a member of the group practice Regents Of The University Of Michigan and his current practice location is 1501 West Chisholm St, Alpena, Michigan. You can reach out to his office (for appointments etc.) via phone at (888) 356-7151.

Kyle Clifford Cuneo is licensed to practice in Michigan (license number 4301100272) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1740464627.

Contact Information

Kyle Clifford Cuneo, MD
1501 West Chisholm St,
Alpena, MI 49707-1401
(888) 356-7151
Not Available



Physician's Profile

Full NameKyle Clifford Cuneo
GenderMale
SpecialityRadiation Oncology
Experience17 Years
Location1501 West Chisholm St, Alpena, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Kyle Clifford Cuneo attended and graduated from Vanderbilt University School Of Medicine in 2007
  NPI Data:
  • NPI Number: 1740464627
  • Provider Enumeration Date: 12/27/2007
  • Last Update Date: 06/21/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 3577712389
  • Enrollment ID: I20121010000379

Medical Identifiers

Medical identifiers for Kyle Clifford Cuneo such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1740464627NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0001XRadiology - Radiation Oncology 4301100272 (Michigan)Primary
2085R0203XRadiology - Therapeutic Radiology RESIDENT, NO LICENSE (Tennessee)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Michigan Health SystemAnn arbor, MIHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Regents Of The University Of Michigan37794968562953

News Archive

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma

A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Kyle Clifford Cuneo allows following entities to bill medicare on his behalf.
Entity NameRegents Of The University Of Michigan
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1083648885
PECOS PAC ID: 3779496856
Enrollment ID: O20031121000686

News Archive

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma

A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.

Read more Medical News

› Verified 3 days ago

Entity NameNortheastern Michigan Cancer Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1275567869
PECOS PAC ID: 0840285904
Enrollment ID: O20040417000515

News Archive

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma

A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.

Read more Medical News

› Verified 3 days ago

Entity NameAdvantage Health/saint Mary's Medical Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1376862151
PECOS PAC ID: 4082807961
Enrollment ID: O20101023000279

News Archive

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma

A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kyle Clifford Cuneo is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kyle Clifford Cuneo, MD
3621 South State Street, 700 Kms Place,
Ann Arbor, MI 48108

Ph: (734) 936-2047
Kyle Clifford Cuneo, MD
1501 West Chisholm St,
Alpena, MI 49707-1401

Ph: (888) 356-7151

News Archive

New study aims to improve the treatment of patients receiving end-of-life care

This landmark study aims to improve the treatment of patients receiving end-of-life care and lead to a more uniform approach and consistent management within the NHS.

Alzheimer's treatments may prove effective if started in middle-aged people: Study

Memory lapses that occur with normal aging are a source of worry for many who fear Alzheimer's disease. Now a new Mayo Clinic-led study published in the July 16 issue of the New England Journal of Medicine suggests that the carriers of a common genetic risk factor for Alzheimer's disease begin to have memory declines in their mid-50s, far earlier than previously thought.

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

Inverted DNA turns quiet developmental gene into a potent driver of t-cell lymphoma

A gene crucial for embryonic development can quickly become a potent cancer promoter in adult mice after a genetic misalignment, according to researchers from Fox Chase Cancer Center, causing white blood cells to become cancerous spontaneously.

Read more News

› Verified 3 days ago


Radiology Doctors in Alpena, MI

James Weeks, MD
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 1501 W Chisholm St, Alpena, MI 49707
Phone: 989-356-7390    
Mario Dante Lacerna, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1501 W Chisholm St, Alpena, MI 49707
Phone: 888-356-7151    Fax: 989-356-8117
Dr. Ben Edward Eggleston, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 704 W Washington Ave, Alpena, MI 49707
Phone: 952-595-1100    Fax: 612-294-4903
Dr. Charles S Spann, M.D.
Radiology
Medicare: Not Enrolled in Medicare
Practice Location: 1501 W Chisholm St, Alpena, MI 49707
Phone: 989-356-7390    
Julie M Forstner, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1501 W Chisholm St, Alpena, MI 49707
Phone: 989-356-7353    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.